We are live on ! Find out more
TG

TRV GP Portfolio holdings

AUM $18.9M
1-Year Est. Return 541.67%
This Fund
S&P 500
This Quarter Est. Return
-14.11%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$20M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYTM icon
1
Rhythm Pharmaceuticals
RYTM
$7.31B
$80.1M 79.96%
2,981,437
– –
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$12.2M 12.14%
3,034,083
– –
CARM
3
DELISTED
Carisma Therapeutics
CARM
$6.88M 6.86%
242,080
– –
LRMR icon
4
Larimar Therapeutics
LRMR
$384M
$1.04M 1.04%
17,531
– –

Similar funds

KA
KSL Advisors Denver, Colorado $16.1M AUM
FRGX
First Reserve GP XII Stamford, Connecticut $3.16M AUM 24.66% 1-Year Est. Return
DHRFI
DCM Hybrid RMB Fund International Menlo Park, California $35.3M AUM
SA
Silversage Advisors Irvine, California $2.41M AUM 46.55% 1-Year Est. Return
YECIP
YT Extraction Co Investment Partners New York $1.73M AUM
FFIM
Founders Fund II Management San Francisco, California $1.32M AUM
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

TRV GP's Q4 2018 Portfolio in Review

As of Q4 2018, TRV GP held 4 positions worth $100M, down 17% from $120M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 0%. TRV GP opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP's ten largest holdings make up 100% of its $100M portfolio in Q4 2018.
  • TRV GP opened 0 new positions and closed 0 in Q4 2018.
  • TRV GP's portfolio value fell 17% quarter-over-quarter to $100M.

Based on TRV GP's 13F filing for Q4 2018, filed 28 Jan 2019.